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Abstract.  We have expressed the human  EGF recep- 
tor (hEGF-R)  in Xenopus oocytes by injecting  mRNA 
synthesized  in vitro using  SP6 vectors containing 
receptor cDNAs.  Each  oocyte could express over  1  × 
10 ~° receptors of a  single affinity class and these were 
able to bind and rapidly  internalize  EGE  Occupancy 
resulted  in receptor tyrosine autophosphorylation, 
downregulation,  and  release of intracellular  calcium. 
Occupied receptors  also rapidly  induced meiotic matu- 
ration  in stage VI oocytes. Receptors lacking  tyrosine 
kinase  activity bound EGF normally,  but did not 
downregulate  or induce any biological  responses.  The 
rate of oocyte maturation  was proportional  to hEGF-R 
occupancy and  was significantly  faster than 
progesterone-induced  maturation  at nanomolar  EGF 
concentrations.  Mutant  hEGF-R truncated  at residue 
973 displayed identical  phenotypes  in both mammalian 
cells and oocytes in that they were defective in their 
ability to release intracellular  calcium,  undergo ligand 
induced internalization  and receptor downregulation. 
However, these receptors  were fully capable of induc- 
ing oocyte maturation.  The remarkable  retention  of 
specific biological activities of different hEGF-R in the 
context of oocytes suggests that  this  receptor  system 
interacts  with generally available cellular components 
that have been conserved during  evolution.  In addi- 
tion,  it suggests that cell surface tyrosine kinase activ- 
ity may play an important  role in regulating  resump- 
tion  of the cell cycle. 
central question in biology is the mechanism by which 
growth  factors  regulate  entry  into  the  cell  cycle. 
Polypeptide mitogens such as EGF bind to specific 
surface receptors which possess intrinsic tyrosine kinase ac- 
tivity (Carpenter,  1985; Cohen,  1983). Phosphorylation of 
cellular substrates on tyrosine residues leads to a multitude 
of responses such as ion transport (Chen et ai., 1987), induc- 
tion of receptor internalization  (Glenney et al.,  1988), gene 
induction,  and  eventually  cell  division  (Carpenter,  1985; 
Chen et al.,  1987). Although receptor tyrosine kinase activ- 
ity is necessary for the mitogenic action of EGF, it has been 
difficult  to  identify  those  events  and  cellular  substrates 
directly involved in regulating  the cell cycle. Partly this is 
due to the plethora of responses to growth factors and the 
asynchronous  movement  of mammalian  cells  through  the 
cell cycle. It is thus difficult to identify a particular biochemi- 
cal event as being crucial to either a specific response or to 
a  responsive subpopulation  of cells.  Indeed,  experimental 
systems which do not suffer from these drawbacks, such as 
yeast and Xenopus oocytes, have proven to be more amenable 
to  studies  on the biochemical  regulation  of the  cell cycle 
(Mailer,  1987;  Simanis et al.,  1987). 
Recent  studies  in  Xenopus oocytes  have  identified  the 
homologue of the yeast cdc2 gene product as a central com- 
ponent  in  the  progesterone-mediated  resumption  of mei- 
osis (Dunphy et al.,  1988; Gautier et al., 1988). This protein 
(p34  ~a~2) is a component of the maturation promoting factor 
(MPF) ~ that appears during  meiosis and has serine kinase 
activity (Labbe et al.,  1989; Simanis et al.,  1987). Numer- 
ous  studies  have  focused  on  the  regulation  of p34  cdc2 by 
other proteins (Draetta et al.,  1989; Dunphy and Newport, 
1989) and p34  cat2 has been identified as a major substrate of 
tyrosine kinases in mammalian cells (Draetta et ai.,  1988). 
Despite a growing body of evidence on how p34  cd~2 is regu- 
lated in cycling cells,  little is known regarding  the mecha- 
nisms of its initial activation (Mailer,  1988). Although most 
studies  have concluded  that phosphorylation  of p34  cdc2 on 
tyrosine residues inhibits its activity (Dunphy and Newport, 
1989; Morla et al.,  1989), tyrosine kinase activity has been 
shown to facilitate oocyte maturation (Mailer, 1987; Morgan 
et al.,  1986). Unfortunately, oocytes lack sufficient numbers 
of receptors possessing tyrosine kinase activity for biochem- 
ical analyses (Mailer and Koontz,  1981). In addition, direct 
microinjection of tyrosine kinases such as the insulin recep- 
tor (Mailer,  1987) and src kinase (Spivack et al.,  1984) into 
oocytes does not trigger maturation.  Thus the relationship 
between activation of growth factor receptor tyrosine kinase 
activity and the p34  c~c2 pathway remains  obscure. 
Since oocytes express foreign proteins when injected with 
a suitable mRNA (Dawid and Sargent,  1988), we sought to 
1. Abbreviations  used in this paper:  GVBD, germinal vesicle breakdown; 
hEGF-R, human epidermal growth factor receptor; Kin  +, tyrosine kinase 
active; Kin-, tyrosine kinase inactive;  MPF, maturation promoting factor. 
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EGF  receptors (hEGF-R)  in  oocytes.  Since a  number of 
cDNA vectors containing site-directed mutants of the hEGF-R 
are available (Chen et al.,  1987), this approach allows ma- 
nipulation of the receptor system at the molecular level. By 
using SP6 vectors to direct the in vitro synthesis of large 
amounts of mRNA for oocyte injection (Krieg and Melton, 
1987), we obtained the expression of over 1 ×  10  l° recep- 
tors per oocyte. Significantly, we found that the hEGF-R can 
function normally in oocytes and its tyrosine kinase activity 
can trigger meiosis. 
Materials and Methods 
Oocyte Isolation and Culture 
Xenopus laevis were purchased from the South African Snake Farm (Fish 
Hock,  Cape Province)  and maintained as previously  described (Opresko 
and Karpf,  1987). Animals were injected with 500 IU hCG at least 2 wk 
before  oocyte  isolation  by  manual  dissection  as  previously  described 
(Opresko and Karpf, 1987). Oocytes were maintained in 50% L-15 medium 
containing 5 % calf serum and 1% BSA (Wallace et al., 1980) for 18 h before 
injection with mRNA. The oocytes were injected with "~20 ng mRNA in 
10-20 nl of water and maintained in the above medium for 40 h before evalu- 
ation. All injections  were  performed with a  custom pneumatic injector 
calibrated by video microscopy. 
Construction of the hEGF-R Vector 
The  pLOLB  vector  was  constructed  from  the  pSP64  (polyA)  vector 
(Promega Biotec, Madison, WI) by replacing the Eco RI linearization site 
with a Not I site.  The pXER vector containing the full-length  cDNA for 
the hEGF-R as well as the M  TM and c'973 truncation mutations were ob- 
tained from Drs. Gordon Gill and Michael Rosenfeld (University of Califor- 
nia, San Diego,  CA).  The hEGF-R cDNAs were excised by cutting  with 
Hind III,  end-filling with Kienow fragment, and then cutting with Xba I. 
The cDNAs were cloned into the pLOLB vector using the Xba I and Sma 
I sites, yielding the pOBER vector. The SP6 RNA polymerase transcription 
initiation site was 95 nucleotides  upstream of the hEGF-R coding  region 
which terminated 310 nucleotides from the polyA tail. This plasmid was lin- 
earized with Not I and mRNA was transcribed using SP6 RNA polymerase 
(Krieg and Melton, 1987). To obtain capped mRNA, diguanosine triphos- 
phate was present in a fivefold molar excess to rGTP. The newly synthesized 
mRNA was treated with RNAse-free  DNAse,  extracted with chloroform/ 
phenol, precipitated and resuspended in DEPC-treated water to a concen- 
tration of 0.5-1.5 #g/#l and frozen in small aliquots.  The concentration of 
mRNA was determined spectrophotometrically after G-50 column chroma- 
tography. 
Receptor Labeling 
The hEGF-R was biosynthetically  labeled by incubating mRNA-injected oo- 
cytes for 48 h in bicarbonate-free,  DME with 10% normal methionine and 
cysteine,  10%  dialyzed  calf serum,  and 20 mM Hepes  buffer,  pH  7.6 
(Wallace and Misulovin, 1978). This medium was diluted 1:1 with 20 mM 
Hepes  buffer  and contained 1 mCi/ml 35S-Translabel (ICN Radiochemi- 
cais,  Irvine, CA).  Groups of five oocytes were homogenized  in 1 ml of 
12.5 mM CHAPS, 10 mM NaC1, 1 mM EDTA 10 mM Tris-C1, pH 8.0 and 
100/zg/ml each aprotinin, leupeptin, chymostatin, and pepstatin, and 3 mM 
PMSE The insoluble residue was removed by centrifugation  and the labeled 
hEGF-R was immunoprecipitated with the 528 mouse monoclonal antibody 
(Gill et al.,  1984). Mouse B82 cells expressing  high levels of the tyrosine 
kinase active (Kin  +) hEGF-R (Glenney et al., 1988) were labeled overnight 
as described above using normal strength DME and 50 #Ci/ml of aSS_ 
Translabel.  Solubilized  immunoprecipitates were  subjected  to  SDS  gel 
electrophoresis  using a 7.5% gel. Gels were treated with EN3HANCE  be- 
fore fluorography. Molecular weights of the labeled bands were determined 
using prestained molecular weight markers (Bio-Rad  Laboratories, Rich- 
mond, CA). 
The presence of phosphotyrosine in the hEGF-R was  determined by 
Western blot analysis. Groups of oocytes injected 40 h previously  with the 
indicated mRNA were incubated either with or without EGE After a 30- 
rain extraction at 0°C with the CHAPS solution described above containing 
10 mM NaF and 0.1 mM Na3VO4, SDS and DTT were added to 1% and 
12 mM respectively.  Samples were boiled and subjected to SDS gel elec- 
trophoresis using 5-15%  gradient gels.  The proteins were transferred to 
nitrocellulose using a PolyBlot apparatus (Fisher Scientific Co., Pittsburgh, 
PA)  and probed with  125I-labeled antiphosphotyrosine monoclonal anti- 
body PY20  (ICN Biochemicals Inc.,  Cleveland, OH) as previously  de- 
scribed (Glenney et al.,  1988). 
Histone Kinase Assay 
The assay for the activation of oocyte histone H1 kinase was based on the 
protocol previously described (Labbe et al., 1988). Groups of three oocytes 
were rinsed once and homogenized in 20 #l of 50 mM/3-glyceropbosphate, 
10 mM MgC12, 7.5 mM EGTA,  1 mM DTT, 20 mM Hepes,  pH 7.5 and 
100/~g/ml each aprotinin, leupeptin,  chymostatin, and pepstatin. Insoluble 
material was removed by centrifugation for 1 min at 8,000 rpm in a tabletop 
swinging  bucket  microfuge  (Savant  Instruments, Inc.,  Hicksville,  NY) 
maintained at 4°C.  Homogenates  (15 #l) were mixed with 5 #l of histone 
reaction mixture (5 mg/ml lysine-rich histories (HmS from Sigma Chemi- 
cal Co.,  St.  Louis,  MO),  15  mM MgC12,  1 mM ATP, and 50 #Ci/ml 
[3,-32P] ATP from Amersham Corp., Arlington Heights, IL). After 10 rain, 
the reaction was terminated by adding 40 #1 of 2% SDS, 2%/~-mereapto- 
ethanol, and boiling for 2 min. The samples were subjected to SDS gel elec- 
trophoresis using 12% gels followed by staining, drying, and autoradiogra- 
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Figure I.  Oocytes injected with mRNA encoding the hEGF-R will 
bind EGE (A) Map of the pOBER vector used to generate mRNA 
in vitro for oocyte injections. (B) Binding of t2SI-EGF to oocytes 
at both 0  and 20°C.  Oocytes were injected with 20 ng mRNA or 
water 40 h  before exposure to radiolabeled ligand,  t2SI-EGF (6.7 
x  108 cpm/nmol) was added at a concentration of 1.7  x  10  -8 M. 
Binding at 0°C was done for 2 h and uptake at 20°C was done for 
1 h.  Each point represents an individual oocyte. 
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Figure 2. Surface expression of the hEGF- 
R. (.4) Groups of oocytes were injected with 
either  water (zx) or with 20 ng of mRNA 
encoding the wild-type hEGF-R and at the 
indicated times were evaluated at 0°C  for 
their ability to bind 125I-EGF at a concen- 
tration of 3.3  x  10  -8 M. Data is shown for 
oocytes  of 1.0-mm diameter  (o) and  1.3- 
mm diameter  (El) -t- the standard error of 
the  mean.  (B)  Scatchard  analysis of ~25I- 
EGF binding to oocytes at 0°C. Oocytes in- 
jected with 20 ng mRNA 40 h earlier were 
brought to equilibrium with :5I-EGF con- 
centrations  ranging  from 5  x  10  -1° to 1.6 
×  10  -7 M.  Each  point  represents  10 oo- 
cytes and receptor affinity was estimated by 
linear regression. 
phy. Quantitation of the amount of label in the bands was determined using 
a densitometer (model 620; Bio-Rad Laboratories). Exposure times of the 
autoradiographs were adjusted to remain in the linear range of the den- 
sitometer as determined by parallel samples of known specific activities. 
EGF Binding to Oocytes 
1 h before binding, the cells were placed into fresh 50% L-15 solution con- 
taining 125 ~g/ml sodium ipodate which inhibits the deiodination activity 
of oocytes (Opresko et al., 1980).  1251-EGF was prepared as previously de- 
scribed (Wiley and Cunningham,  1982).  Scatchard analyses (Scatchard, 
1949)  were performed at  0°C  to prevent internalization.  Oocytes were 
brought to equilibrium (4-6 h) with 125I-EGF concentrations ranging from 
5  x  10  -~° to 1.6  ×  10  -7 M. The labeled EGF was not diluted with unla- 
beled EGF to avoid potential problems associated with differential binding 
between labeled and unlabeled ligand (Wiley, 1985).  A minimum of 10 oo- 
cytes  were  used  to  evaluate  binding  at  each  125I-EGF concentration, 
Nonspecific binding was determined in parallel using water-injected oo- 
cytes and was always <10 % of total binding. To allow internalization, oo- 
cytes were incubated at 20°C for the indicated times. After the incubation, 
cells were washed in three changes of solution O-R2 (Wallace et al., 1973) 
containing 1 mg/ml BSA at 0°C. The relative amount of surface-associated 
and internalized 125I-EGF was determined by acid stripping groups of two 
cells as described previously (Wiley and Cunningham, 1982). Oocytes were 
solubilized in groups of two using 100 #1 formic acid before counting. The 
data were corrected for nonspecific binding and converted to internalization 
plots as previously described (Opresko and Wiley,  1987b).  Steady-state 
binding of EGF was also conducted at 20°C for 2 h using 125I-EGF con- 
centrations ranging from 5  ×  10  -1° to  1.6  ×  10  -7 M  as previously de- 
scribed (Knauer et al.,  1984;  Wiley and Cunningham,  1981). 
Calcium Efflux Measurements 
Oocytes injected with the appropriate mRNA 40 h earlier were incubated 
overnight with 50/zCi/ml of 4SCa (Amersham Corp.) in standard culture 
medium. Before the efflux measurements, the oocytes were rinsed rapidly 
in three changes of solution OR-2 and placed in the upper chamber of an 
equilibrium dialysis flow cell (Womack and Colowick, 1973).  The oocytes 
were supported on nylon mesh and the upper chamber (volume 0.5 ml) was 
sealed with parafilm.  The  lower flow chamber  (100  /zl) was constantly 
stirred with a small magnetic bar and solution OR-2 was pumped through 
at a flow rate of 1.5 ml/min. Fractions were collected at 1-min intervals and 
the amount of radioactivity assessed by scintillation counting. The amount 
of 45Ca remaining in the oocytes after the experiment was released by de- 
tergent and counted. 
Results 
Expression of  High Levels of EGF Receptors in Oocytes 
Efforts to induce the synthesis of the hEGF-R by injecting 
total polyA mRNA from A431 cells (Simmen et al.,  1984) 
did  not  result  in  any  observable  ~25I-EGF binding  by oo- 
cytes.  We therefore obtained the pXER expression vector 
containing the cDNA encoding the full-length hEGF-R (Lin 
et al., 1986). Direct microinjection of this vector into the oo- 
cyte nucleus  resulted  in  a  significant,  but highly  variable 
binding of ~25I-EGF to recipient cells (data not shown).  To 
improve the reproducibility of hEGF-R expression, we con- 
structed the vector shown in Fig.  1 A. This vector supports 
the in vitro synthesis of hEGF-R mRNA containing a  30- 
residue polyA tail. Injection of this polyA mRNA resulted in 
very  efficient  synthesis  of hEGF-R  by  recipient  oocytes. 
Shown  in  Fig.  1 B  is  the  net  binding  of ~:SI-EGF to  in- 
dividual oocytes at both 0 and 22°C. Binding of ~25I-EGF to 
mRNA-injected oocytes at 0°C, a temperature that prevents 
receptor  internalization,  was  usually  10-fold  greater than 
water-injected controls.  However, a  significant increase in 
~25I-EGF binding was observed at 22°C, probably as a con- 
sequence of ligand internalization. To separate the contribu- 
tion of surface receptor expression from receptor internali- 
zation,  we  examined  t25I-EGF  binding  at  0°C  and  then 
analyzed the ability of the expressed receptors to internalize 
ligand. 
Groups  of oocytes  were  injected  with  either  water  or 
mRNA and cultured for different lengths of time. The ability 
of oocytes to oocytes to bind ~25I-EGF at 0°C in both stage 
IV/V (1.0 mm) and VI (1.3 mm) oocytes was then evaluated. 
As shown in Fig. 2 A, significant ~25I-EGF  binding could be 
observed by 24 h and this continued to increase for the entire 
period of the experiment.  The  1.0-mm-diam oocytes accu- 
mulated surface hEGF-R at a rate of ~7  ×  107 h -I between 
24- and 72-h postinjection while the accumulation rate ofoo- 
cytes  1.3-mm diameter was  ~2.3  x  108  h -~.  Within  this 
period, there was no sign of an upper limit in the number of 
receptors observed on the oocyte surface. Even after correct- 
ing for differences in oocyte volume and surface area, stage 
VI oocytes were  still  more efficient in expressing surface 
hEGF-R, consistent with previous observations that protein 
synthesis rates in these cells are significantly higher than in 
smaller oocytes (Wasserman et al.,  1984). 
The hEGF-R expressed by stage VI oocytes were of a sin- 
gle affinity class.  Shown in Fig.  2 B  is a Scatchard plot of 
~25I-EGF binding to mRNA-injected oocytes at 0°C.  Non- 
specific binding  to  water-injected  oocytes at 0°C  usually 
ranged  between 5  and  10%  and  equilibrium  binding  was 
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pressed  by oocytes  is full length and dis- 
plays  EGF-induced  autophosphorylation. 
(A) Immunoprecipitation  of metabolically 
labeled  hEGF receptor.  Oocytes were  in- 
jected with mRNA encoding either the nor- 
mal  hEGF-R  (Kin  +)  or  the  hEGF-R  in 
which lysine at position 721 was altered to 
a methionine by site-directed  mutagenesis 
(Kin-).  Metabolically  labeled  hEGF-R 
from mouse B82 cells were used as a con- 
trol.  After 40-h labeling, the receptor  was 
immunoprecipitated  using the  528  mono- 
clonal antibody. (B) Western blot analysis 
of EGF-induced  tyrosine  phosphorylation 
in oocytes. Stage V oocytes injected 40 h 
previously with the indicated mRNA were 
incubated either  with (4-) or without (-) 
1.7  x  10  -8 M EGF for 5 min followed by 
extraction and Western blot analysis using 
~25I-labeled antiphosphotyrosine  monoclo- 
nal PY20 (Glenney et al.,  1988). 
achieved by 4 h (data not shown).  Although normal human 
fibroblasts also express receptors of a  single affinity class 
(Carpenter et al.,  1975;  Knauer et al.,  1984), the calculated 
equilibrium affinity for the hEGF-R in oocytes was 3.6  x 
10  -s M,  which is '~10-fold lower than that observed in hu- 
man fibroblasts (Wiley et al.,  1989). In the experiments shown 
in Fig. 2 B, each oocyte expressed ,~1.5  ×  101° hEGF-R, or 
'~100-fold the number of endogenous insulin/IGF-1  recep- 
tors (Mailer and Koontz,  1981). 
The absolute number of surface hEGF-R expressed by oo- 
cytes depended both on the amount of injected mRNA, the 
particular batch of oocytes, the oocyte stage, and the time al- 
lowed for synthesis. Typically, this number ranged between 
3  ×  109 and 3  ×  101° receptors/oocyte. However, the sur- 
face area of a  1.0-mm oocyte is approximately that of 50,000 
fibroblasts (Opresko and Wiley, 1987a), translating to a sur- 
face receptor density equivalent to between 0.6 and 6  ×  105 
for a typical mammalian cell. Although this receptor density 
is  high,  it  falls  within  the  range  reported  for  transfected 
mammalian cells and is substantially less than that observed 
for A431 cells (Chen et al.,  1987;  Haigler et al.,  1979).  In 
addition,  the number of endogenous vitellogenin receptors 
expressed on  the  oocyte surface  is  between  0.3  and  3  × 
10"  (Opresko and Wiley,  1987a).  Thus the  surface densi- 
ties of hEGF-R expressed by oocytes is high, but well within 
the capacity of the oocyte plasma membrane. 
We also synthesized mRNA from a  hEGF-R cDNA that 
contains methionine rather than lysine at residue 721  (Chen 
et al.,  1987).  Receptors made from this mutant cDNA lack 
intrinsic tyrosine kinase activity, but are unaltered in their 
ability to bind EGF (Chen et al.,  1987).  Oocytes injected 
with mRNA derived from the "wild-type" (Kin  +) and M  TM 
(tyrosine kinase inactive  [Kin-]) constructions  synthesized 
equivalent  numbers  of receptors as  a  function  of injected 
mRNA and both bound EGF with the same affinity (data not 
shown). 
To determine whether these receptors were normally pro- 
cessed,  oocytes  were  incubated  with  [35S]methionine/cys- 
teine followed by immunoprecipitation with a  monoclonal 
antibody to the hEGF-R (Gill et al., 1984). As shown in Fig. 
3 A, a protein was immunoprecipitated with the same mobil- 
ity  as  the  hEGF-R  synthesized by transfected mammalian 
cells. The additional bands found in the oocyte immunopre- 
cipitate are nonspecifically adsorbed,  sulfated yolk proteins 
The Journal  of Cell Biology, Volume 111, 1990  1664 8.0  I1" 
60  A 
// 
g  2.0  v  •  Surface 
60  .....  ' 
~  B  Inside 
i  4.0  ~  ta~ 
O  [] 
2.0  j  Surface 
ong."  o--  -  -  o- 
0.0  .  ,  .  ,  .  ,  .  , 
0  20  40  60  80 
Time  (rain) 




E  0.0  2'.0  410  6.0 
Integral surface binding (molecules x rain x 10 -9) 
Figure 4. Internalization and down-regulation of the kinase positive 
and kinase negative hEGF-R by oocytes. (A) Binding and internali- 
zation of Kin* (•,  m) receptors.  Oocytes were incubated  with 3.3 
×  10  -8 M  t25I-EGF (5.7  ×  108 cpm/nmol) and at the  indicated 
times groups of eight oocytes were rinsed  and the relative  amount 
of  surface-associated  and  internalized  ~25I-EGF determined  by 
acid  stripping.  (B)  Binding  and  internalization  of Kin-  (o,  []) 
receptors.  Same experiment  described in A, but the oocytes were 
injected  with mRNA derived from the Kin- hEGF-R.  (C) Inter- 
nalization  plots of the Kin  + (•)  and Kin- (o) receptors.  The ki- 
netics of internalization  was determined as described above using 
1.7  ×  10  -9 M  125I-EGF  and the data were transformed  into inter- 
nalization  plots.  The  slope  of these  plots  is  proportional  to the 
specific internalization  rate of the receptor,  yielding a value of 0. 21 
min  -1 for the Kin + receptor,  and 0.11 min  -t for the Kin- receptor. 
The EGF Receptor Is Fully Functional in Oocytes and 
Induces Meiotic Maturation 
Our ability to synthesize hEGF-R in oocytes allowed us to 
test which functional aspects of the receptor are intrinsically 
dependent  on  tyrosine  kinase  activity.  For  example,  the 
Kin-  hEGF-R  in mammalian  cells  is  unable  to transmit  a 
biological signal (Chen et al.,  1987) or to trigger receptor 
downregulation  (Glenney  et al.,  1988).  Kin-  receptors  do 
not undergo downregulation because of their lack of ligand- 
induced internalization.  We therefore examined the relative 
ability of Kin  + and Kin- hEGF-R to induce these events in 
the  oocytes.  To  determine  whether  both  Kin  +  and  Kin- 
hEGF-R  undergo endocytosis and  downregulation,  we in- 
cubated oocytes with a high concentration of ~2q-EGE The 
extent of internalization and surface binding was then quanti- 
tated by acid stripping  (Wiley and Cunningham,  1982).  As 
shown in Fig. 4, both Kin  + and Kin- receptors internalized 
EGE  However, the specific internalization  rate of the Kin  + 
receptor was about twice that of its Kin- counterpart  (Fig. 
and are also found in sham-injected oocytes (data not shown). 
The molecular weight of the labeled band was  170,000,  in- 
dicating  that  the  hEGF-R  is  fully  glycosylated by oocytes 
(Soderquist et al.,  1988). 
The tyrosine kinase activity of the hEGF-R in oocytes was 
determined by Western blot analysis using an anti-phospho- 
tyrosine  (anti-pTyr)  monoclonal antibody  (Glenney  et  al., 
1988). As seen in Fig. 3 B, only oocytes injected with mRNA 
encoding  the  Kin  + hEGF-R  showed  an  EGF-mediated  ap- 
pearance of a new tyrosine-phosphorylated protein. The mo- 
lecular weight of the EGF-induced band was 170,000,  indi- 
cating that it is the autophosphorylated hEGF-R (Downward 
et al., 1984). These results demonstrate that oocytes can syn- 
thesize  a  fully  glycosylated  and  enzymatically  functional 
EGF receptor. 
Figure 5.  Occupied EGF receptors can induce meiotic maturation 
in oocytes. (A) Kinetics of EGF and progesterone-induced matura- 
tion.  Oocytes injected with mRNA encoding the Kin  + (e) or Kin- 
(o) hEGF-R were exposed to  1.7  x  10  -8 M  EGE Alternatively, 
water-injected  oocytes were  exposed  to  10  #g/ml  progesterone 
([]). At the indicated times, they were scored for the appearance of 
the characteristic white spot at the apex of the animal hemisphere, 
indicating  GVBD.  (B)  Effect  of EGF concentration on the  rate 
of maturation.  Groups of oocytes (n  =  7)  expressing  the  Kin  + 
hEGF-R were treated  with the indicated  concentrations of EGE 
The time of GVBD was then scored as indicated  in A. The results 
are shown as the mean time of GVBD  +  the standard deviation. 
Control oocytes were treated with  10/,g/ml progesterone. 
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third the  initial values by 80  min in cells expressing Kin  + 
receptors while  surface binding  for the  Kin- receptor re- 
mained  constant.  This  indicates  that  Kin  + receptors  are 
undergoing ligand-induced internalization and downregula- 
tion,  consistent with  the  observations of higher  internali- 
zation rates for the Kin  + receptor. To confirm downregula- 
tion of Kin  + receptors, we conducted a "steady state" analysis 
of surface binding (Wiley and Cunningham,  1981) at 22°C 
to allow for endocytosis (Wallace et al., 1973). Oocytes were 
incubated  with  increasing  concentrations  of t25I-EGF  and 
allowed to approach a  steady state of surface binding.  The 
maximum extent of surface binding was then determined by 
extrapolation and compared to equilibrium binding at 0°C. 
The results of this experiment showed that oocytes that dis- 
played an  average of 2.4  x  101° receptors at 0°C  (before 
EGF exposure) had a maximum of 8.5  ×  109 surface recep- 
tors at steady state binding. This confirms that oocytes lose 
approximately two-thirds of their surface receptors by down- 
regulation.  The absence of downregulation  of Kin- recep- 
tors does not seem to be due to differences in their ability 
to recycle relative to Kin  + receptors.  EGF internalized by 
either receptor is transferred to a light endosomal compart- 
ment and eventually to yolk platelets (data not shown). This 
indicates that intrinsic kinase activity induces hEGF-R down- 
regulation at the level of internalization in oocytes as it does 
in mammalian cells (Chen et al., 1987; Glenney et al., 1988). 
To determine whether the hEGF-R could induce a biologi- 
cal response in oocytes, we examined the effect of EGF on 
meiotic maturation. It has already been established that in- 
cubating  oocytes  with  high  concentrations  of insulin  and 
IGF-1 can facilitate and sometimes induce oocyte maturation 
(LeGoascogne et al., 1984; Mailer and Koontz, 1981). How- 
ever,  since microinjected tyrosine kinases  such  as the src 
protein or insulin receptor cannot induce maturation (Mailer, 
1987;  Spivack et al.,  1984),  a  direct relationship between 
tyrosine  kinase  activity  and  maturation  is  uncertain.  We 
therefore  compared the  relative ability  of EGF  to  induce 
maturation  in  oocytes expressing  either  the  Kin  + or  Kin- 
hEGF-R. As shown in Fig. 5 A, EGF was very effective in 
inducing maturation in oocytes that expressed the Kin  + re- 
ceptor.  However, treatment of oocytes expressing Kin- re- 
ceptors with EGF was without effect, even after 24-h treat- 
ment.  In  addition,  neither  water-injected  nor  uninjected 
oocytes  responded  to  EGE  Germinal  vesicle  breakdown 
(GVBD) in EGF-treated oocytes was confirmed by section- 
ing of fixed oocytes. Cytoplasm from EGF-matured oocytes 
could also induce maturation in recipient oocytes with the 
same  kinetics  as  cytoplasm from progesterone-stimulated 
oocytes (data not shown),  confirming the presence of MPF 
(Wasserman and Masui,  1975a). 
We were quite  surprised to find that EGF could induce 
maturation significantly faster than progesterone (Fig. 5 B). 
However, the rate of EGF-induced maturation was highly de- 
pendent on both the concentration of EGF and the level of 
hEGF-R expression at the oocyte surface. As shown in Fig. 
5  B,  reducing  the  concentration  of EGF resulted  in  a  de- 
crease in the rate of maturation to below that observed for 
progesterone. When the level of surface hEGF-R expression 
was decreased to below  109 per oocyte, the maximum rate 
of EGF-stimulated maturation also fell below that typically 
induced  by  progesterone,  but  was  still  much  faster  than 
insulin-induced maturation (data not shown).  However, we 
occasionally found batches of oocytes in which progesterone 
induced maturation nearly as fast as that induced by EGE 
Therefore, the mechanism(s) which regulates the sensitivity 
of oocytes to progesterone does not necessarily affect their 
sensitivity to EGE  Nevertheless,  the intrinsic  tyrosine ki- 
nase activity of the EGF receptor is essential for the induc- 
tion of maturation and EGF can stimulate oocyte responses 
at physiological ligand concentrations. 
Activation of the MPF/p34  c~2 Complex 
Progesterone-stimulated maturation involves the activation 
of the MPF/p34  ~dc2 complex which contains a  serine/threo- 
nine histone H1 kinase activity (Arion et al.,  1988;  Labbe 
et al.,  1989).  The activation of the MPF/p34 cdc2 complex is 
thought  to  be  essential  for  subsequent  events  in  meiosis. 
However, the rapid maturation stimulated by EGF and its de- 
EGF in oocytes expressing the Kin  + (e) or Kin- (o) hEGF-R or in response to 10/zg/ml progesterone (D). 
(bottom) under the same conditions described  in the top panel. 
Figure 6. Activation ofhistone 
kinase activity in response to 
EGE  (A)  Autoradiograph  of 
in vitro phosphorylation of his- 
tones by oocyte extracts. Con- 
trol oocytes were treated with 
progesterone  (top),  whereas 
oocytes injected with mRNA 
encoding the Kin  + (center) or 
Kin- (bottom)  hEGF-R  were 
exposed to 1.7  x  10  -s M EGE 
At the indicated times, oocyte 
extracts were evaluated  for their 
ability to catalyze histone phos- 
phorylation.  Shown  is  the 
histone  region of the autora- 
diograph.  (B)  Densitometric 
quantitation  of histone  phos- 
phorylation  (top) induced  by 
Kinetics of oocyte maturation 
The Journal of Cell Biology, Volume 111, 1990  1666 2.0 
•  1.5 
x 
~  1.0 
8 
~  0.5 
0.0 
S.0- 
%  . 
×  4.0- 
,,,  3.0. 
•  -  2.0. 











5.0  10  15  20 
Integral surface binding (molecules x min'lx 10  -10) 
Figure  7.  Internalization  and  downregulation  of c'973  hEGF-R  in 
oocytes. Stage VI oocytes were injected with 20 ng of mRNA en- 
coding the wild-type hEGF-R (e) and receptors truncated at resi- 
due 973 (n). After 40-h culture, oocytes were evaluated at 22°C 
for their ability to approach steady state surface binding (A) as well 
as internalize ~25I-EGF (B) using a ~25I-EGF concentration of 1.7 
X  10  -9 M. 
pendence on tyrosine kinase activity is difficult to reconcile 
with the observation that activation of the p34  cdc2 complex is 
correlated with removal of its tyrosine phosphate (Dunphy 
and  Newport,  1989;  Gautier et  al.,  1989;  Morla  et  al., 
1989). To determine the relationship between hEGF-R tyro- 
sine kinase activity and the activation of the  MPF/p34  cdc2 
complex, we measured histone H1  kinase activity in both 
progesterone and EGF-treated oocytes. As shown in Fig. 6, 
progesterone induced a dramatic increase in histone kinase 
activity prior to GVBD. These results are essentially identi- 
cal to those reported by other investigators (Labbe et al., 
1988).  In oocytes expressing the Kin  + hEGF-R,  the addi- 
tion of EGF resulted in a very similar activation in histone 
kinase activity (Fig. 6). Significantly, there was no measur- 
able increase in this activity for several hours after the addi- 
tion  of EGE  As  expected,  oocytes  expressing  the  Kin- 
hEGF-R showed no response to the addition of EGF (Fig. 
6). However, these cells did respond normally to the addition 
of progesterone (data not shown).  The delay between the 
activation of the hEGF-R and the  activation of the MPF/ 
p34  cdc2 complex indicates either that internalization of the 
ligand- receptor complex is required, or that the activation 
is indirect. 
Expression of an Internalization-defective hEGF-R 
in Oocytes 
When we first examined the effect of EGF on oocyte matura- 
tion,  we noted that  oocytes expressing the Kin  + hEGF-R 
appeared morphologically normal until '~6-8 h after EGF 
addition. After this time, oocytes became mottled and then 
visibly degenerated.  This is  similar to what has been ob- 
served  for  maturation  induced  by  both  H-ras  injection 
(Birchmeier et al.,  1985), high concentrations of divalent 
cations and ionophores (Wasserman and Masui, 1975b), and 
other nonphysiological agents  that can affect intracellular 
calcium distribution (Smith,  1989). Although the hEGF-R 
can release intracellular calcium in mammalian cells (Sawyer 
and Cohen,  1981), progesterone treatment does not induce 
calcium release in oocytes (Cork et al., 1987). Therefore, we 
felt that this additional response could be responsible for the 
eventual oocyte degeneration.  To test this  hypothesis,  we 
made use of a recently described mutant of the hEGF-R that 
lacks  the  carboxyl-terminal domain distal to residue 973 
(c'973 hEGF-R). This receptor has full kinase activity, but 
is  defective in  its  ability  to  release  intracellular  calcium 
and to undergo ligand-induced internalization (Chen et al., 
1989). Significantly, the c'973 receptors are fully capable of 
inducing mitosis in mammalian cells,  suggesting that cal- 
cium release and induced internalization are not required for 
induction of cell division. We were thus interested to deter- 
mine whether these receptors would induce meiotic matura- 
tion in oocytes without causing oocyte degeneration. 
We inserted the c'973 hEGF-R into our SP6 vector and 
synthesized the appropriate mRNA. When injected into oo- 
cytes, this mRNA directed the synthesis of a  150,000-kD 
hEGF-R protein, as determined by [35S]methionine/cysteine 
labeling followed by immunoprecipitation (data not shown). 
This is the expected size of the c'973 hEGF-R.  When in- 
jected with the same amount of mRNA, ~25I-EGF  binding at 
0°C to oocytes expressing the c'973 receptor was indistin- 
guishable from those expressing the wild-type receptor (data 
not shown). We also obsezved that the addition of EGF did 
not result in autophosphorylation of the receptor molecule, 
confirming that all of the autophosphorylation sites had been 
removed by the c'973 truncation. 
Since the c'973 receptor is internalization defective and 
+EGF  Rinse  +lonornydn 
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Figure 8. EGF-induced release of intracellular calcium by oocytes 
expressing wild-type and c'973 receptors. Groups of 50 oocytes in- 
jected 40 h previously with 20 ng of mRNA encoding the appropri- 
ate receptor were preloaded overnight with 45Ca and placed in a 
continuous  flow chamber. Calcium  released  in  the  perfusion 
medium  was  then  monitored  as  described  in  Materials  and 
Methods. At the indicated time, perfusion medium containing 1.7 
x  10  -9 M EGF was used,  followed by a change to initial buffer 
(rinse) followed by buffer containing 10 ~M ionomycin. 
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were interested in confirming this receptor attribute in oo- 
cytes. As shown in Fig. 7 B, internalization plot analysis dem- 
onstrated  that the  specific internalization  rate of the c'973 
receptors was significantly lower than the K ÷ hEGF-R.  On 
the  average, the  internalization  rate of the c'973  was 0.03 
min  -~, or between 35 and 40% of the rate observed in par- 
allel sets of oocytes expressing the wild-type K ÷ hEGF-R. 
As expected, surface binding of ~25I-EGF  to oocytes express- 
ing the wild-type hEGF-R displayed a  time-dependent de- 
crease at 20°C  as a  consequence of downregulation  while 
surface  binding  to  oocytes expressing  the  c'973  hEGF-R 
reached a constant steady state binding (Fig. 7 A). Binding 
at 0°C confirmed that treatment of oocytes expressing c'973 
hEGF-R with high concentrations of EGF for 2  h  at 20°C 
did not decrease the initial number of surface receptors (data 
not shown). We conclude that the internalization/downregu- 
lation defective phenotype of the  c'973  receptor in  mam- 
malian cells is preserved in Xenopus oocytes. 
To determine the relative ability of the different hEGF-R 
to release intracellular calcium stores in oocytes, cells ex- 
pressing the appropriate receptor were loaded overnight with 
45Ca, rinsed, and placed in a continuous flow chamber. The 
Figure 9. EGF-induced maturation of oocytes expressing the c'973 
hEGF-R.  (A)  Uninjected  oocytes  treated  for 8 h with  10 /zg/ml 
progesterone. (B) Oocytes were injected with 20 ng of mRNA en- 
coding the c'973 hEGF-R and 40 h later were treated with  1.7  × 
10  -9 M EGF for 8 h.  The EGF-treated  oocytes  matured  at  3 h 
while the progesterone-treated  cells matured  at 4 h. 
release of 45Ca from the  oocytes was then evaluated  after 
adding EGF to the perfusate. As shown in Fig. 8, the addition 
of EGF to oocytes expressing the wild-type hEGF-R resulted 
in a rapid release of preloaded 45Ca. Water-injected oocytes 
or those expressing Kin- receptors displayed no response to 
the addition of EGF (data not shown). In contrast to the situ- 
ation with the wild-type receptor, EGF addition to oocytes 
expressing the c'973 receptor resulted in very little release of 
45Ca. However, oocytes could release calcium in  response 
to ionomycin (Fig. 8). The relative ability of EGF to induce 
calcium release in  oocytes expressing  either  wild-type or 
c'973 hEGF-R is essentially identical to what has been ob- 
served in mammalian cells (Chen et al.,  1989). 
Once we had confirmed that the cX)73 hEGF-R preserved 
their phenotype in the Xenopus oocyte system, we examined 
the question of whether they could induce meiotic matura- 
tion. We found that the addition of EGF to oocytes express- 
ing c'973 hEGF-R indeed resulted in rapid meiotic matura- 
tion.  However, the rate of maturation we observed was not 
significantly different than what we had observed after stim- 
ulation of oocytes expressing the wild-type receptor. In addi- 
tion, the number of occupied receptors required for induc- 
tion of maturation was similar between the  wild-type and 
c'973 receptors (data not shown). This indicates that the sig- 
naling mechanism required for the induction of maturation 
is not significantly different between the two receptor con- 
structions.  However, as shown in Fig,  9,  the morphology 
of oocytes matured in response to the c'973 hEGF-R was in- 
distinguishable from that displayed by oocytes that matured 
in  response  to  progesterone.  Prolonged  incubations  with 
EGF did not result in any visible abnormalities or morpho- 
logical changes, other than those normally associated with 
maturation. Thus the removal of the internalization/calcium 
domain from the hEGF-R results in a receptor which is fully 
capable of inducing meiotic maturation, but which does not 
trigger the negative side effects observed with the wild-type 
receptor. 
Discussion 
Our results show that the human EGF receptor system can be 
functionally reconstituted in Xenopus oocytes. Other investi- 
gators have previously reported the synthesis of hEGF-R by 
oocytes after injection of mRNA derived from A431  cells 
(Simmen et al.,  1984),  but  insufficient numbers were ob- 
tained for biological or biochemical studies.  Our approach 
of synthesizing mRNAs in vitro from cDNA vectors allowed 
us to obtain sufficient amounts of mRNA to cause high levels 
of receptor expression. Indeed, the levels of surface receptor 
expression we observe (over 10 ~° per oocyte) approach that 
of many transfected mammalian cells (Chen et al.,  1989). 
The Xenopus oocyte is particularly useful for investigating 
the  EGF  receptor  because  they  constitute  a  large,  syn- 
chronized cell population with well-defined,  stage-specific 
responses to growth factors (Maller, 1987; Taylor and Smith, 
1987; Wallace and Misulovin, 1978). They also lack endoge- 
nous  EGF receptors.  The lack of ~25I-EGF binding  to oo- 
cytes that we and other investigators have observed is  not 
simply due to their inability to bind mammalian EGF since 
the  ligand  can  readily  bind  to  Xenopus hepatocytes  at 
nanomolar concentrations as well as induce DNA synthesis 
and receptor autophosphorylation (Wolffe et al.,  1985). The 
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which functional aspects of the receptor system are intrinsic 
to the receptor molecule itself, and those which require cel- 
lular components that are EGF receptor specific. The results 
of our study indicate that virtually all important aspects of 
this receptor system are intrinsic to the receptor molecule 
itself. 
Analysis of 125I-EGF binding to oocytes revealed a single 
affinity class of receptors at both 0°C (Fig. 1 B) and at 22°C 
(data not shown).  However, this affinity (~36 nM at both 
temperatures) was  quite low  relative to mammalian  cells 
(Wiley et al., 1989). It has been reported that some cell types 
display multiple classes of EGF receptors, with the "high 
affinity" type being the ones active in  signal  transduction 
(Defize et al., 1989). However, many cells display only a sin- 
gle, low affinity class of EGF receptors and yet still retain 
full responsiveness to EGF (Knauer et al.,  1984). We have 
previously proposed that the apparent affinity of cells for 
EGF can be dependent on factors extrinsic to the receptor 
itself, such as cell geometry, receptor density, and distribu- 
tion (Wiley, 1985,  1988). The low affinity that we observe 
for the hEGF-R is most likely due to geometric and physical 
aspects of oocytes (such as the thick vitelline envelope) since 
the endogenous oocyte vitellogenin and insulin receptors are 
both  primarily  low  affinity  (Mailer  and  Koontz,  1981; 
Opresko and Wiley,  1987a).  A  significant connection be- 
tween receptor affinity and signal transduction is unlikely, 
since despite the low affinity of hEGF-R expressed in oo- 
cytes, we were able to  generate significant biological re- 
sponses at subnanomolar EGF concentrations. 
The hEGF-R binds and rapidly internalizes EGF (Fig. 4 
C) at rates comparable to mammalian cells (Wiley,  1985). 
EGF also induced endocytic downregulation (Fig. 4 A). The 
role of receptor tyrosine kinase activity in these processes is 
the  same  in oocytes as  in mammalian  cells  (Chen et al., 
1987;  Glenney et al.,  1988)  since it was required both for 
maximal rates of internalization and receptor downregula- 
tion.  Removal of the carboxy region distal to residue 973 
also eliminated downregulation as observed in mammalian 
cells (Chen et al.,  1989). However, absolute differences be- 
tween the specific internalization rates of the Kin  + and Kin- 
receptors were not as pronounced in oocytes as in mam- 
malian cells. Typically, we have observed a 6-10-fold greater 
internalization  rate  of the  Kin  + versus  Kin-  receptor  in 
transfected mammalian cells (Chen et al., 1989), but we only 
observed a two- to three-fold difference in oocytes. However, 
since  downregulation  of the  hEGF-R  is  due  to  ligand- 
induced  (kinase-dependent)  internalization  (Chen  et  al., 
1989), we expected to see correspondingly less downregula- 
tion. This was indeed the case since the extent of hEGF-R 
downregulation was only '~66 % in oocytes as compared to 
the  80-95%  observed in  mammalian  cells  (Chen  et  al., 
1989; Knauer et al.,  1984). The source of this quantitative 
difference between the oocyte and mammalian  systems is 
currently unknown,  but most likely is  a  result of the ex- 
tremely high endocytic capacity of Xenopus oocytes (Opres- 
ko and Wiley, 1987b) since this would narrow differences be- 
tween constitutive and ligand-induced internalization rates. 
Nevertheless, the dependency of downregulation on both ki- 
nase activity and specific domains in the carboxy region of 
the receptor argues that the mechanisms of EGF-induced in- 
ternalization are probably the same in all cells. 
The hEGF-R could also trigger a rapid release of intracel- 
lular calcium from oocytes. As was the case with mammalian 
cells (Chen et al.,  1989), the ability of the hEGF-R to medi- 
ate this response was severely attenuated by removal of the 
receptor domain distal to residue 973 (Fig. 8). Removal of 
this  sequence also  decreased receptor internalization and 
prevented ligand-induced receptor downregulation (Fig. 7). 
To date, all phenotypic differences that have been observed 
between different mutant hEGF-R in mammalian cells have 
also  been  observed in  Xenopus  oocytes.  The  remarkable 
retention of specific biological activities of the hEGF-R in 
the context of oocytes suggests that this receptor system in- 
teracts  with  generally  available  cellular  components  that 
have been conserved during evolution. 
We were quite surprised at the ability of the hEGF-R to 
rapidly induce meiotic maturation. A wide variety of phar- 
macological agents, receptors, oncogenes, kinases, and en- 
zymes have been injected into oocytes to determine their 
ability/role in inducing meiotic maturation (Birchmeier et 
al.,  1985;  Huchon et al.,  1981; Mailer,  1987; Sehgal et al., 
1988; Smith,  1989). This usually results in a "facilitation" 
of progesterone-induced maturation, but rarely maturation 
itself. Tyrosine kinases in particular have been poor inducers 
of maturation.  Although directly injected src kinase (Spi- 
vack et al.,  1984) and insulin receptors (Mailer,  1987) will 
increase ribosomal protein $6 phosphorylation, they do not 
trigger maturation. Insulin and IGF-1 will facilitate proges- 
terone-induced maturation in isolated oocytes (Hirai et al., 
1983;  LeGoascogne et al.,  1984),  but trigger maturation 
only rarely (Wallace and Misulovin, 1980) unless nonphys- 
iological conditions are used, such as removal of potassium 
from the medium (Cicirelli et al.,  1988). We have never ob- 
served insulin-induced maturation in Xenopus oocytes using 
standard conditions (i.e., physiological salines), although we 
have shown that insulin is a potent stimulator of vitellogenin 
uptake  and  oocyte growth  (Opresko  and  Wiley,  1987b). 
Therefore, the role of tyrosine kinases in the induction of oo- 
cyte maturation  has  been  uncertain.  Our  result  with  the 
reconstituted hEGF-R is the first direct evidence that tyro- 
sine kinases can trigger the resumption of meiosis in oocytes. 
Other than MPF itself, the hEGF-R seems to be the most 
effective inducer of meiotic maturation yet described. This 
may be partially due to the high levels of receptors that are 
expressed, since lower receptor occupancies resulted in pro- 
gressively slower response times (Fig. 5 B).  However, the 
levels of  hEGF-R we achieve in our system are less than those 
used by other investigators who directly microinjected mat- 
uration-inducing proteins such as the Harvey ras oncogene 
(Birchmeier et al.,  1985). In addition, occupancy of only a 
small fraction of surface receptors was required to induce 
maturation (<5 %). As a function of surface area, these num- 
bers are comparable to the receptor levels available on Xeno- 
pus  hepatocytes (Wolffe et al.,  1985)  and  normal human 
fibroblasts (Carpenter et al.,  1975)  and are similar to the 
number of endogenous IGF-1/insulin receptors (Mailer and 
Koontz, 1981). As a function of cell mass, oocyte expression 
of the hEGF-R is only a small fraction of the levels displayed 
by other cells.  Thus the ability of the hEGF-R to induce 
maturation does  not appear to be a  nonspecific result of 
receptor overexpression, but instead to be an intrinsic prop- 
erty of the receptor tyrosine kinase activity. 
Even though the hEGF receptor is capable of inducing 
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directly activate the MPF/p34  cdc2 complex. We were unable 
to induce maturation in the smaller  stage  IV  oocytes that 
were  unresponsive  to  progesterone  (data  not  shown)  al- 
though the hEGF-R was fully capable of undergoing EGF- 
induced autophosphorylation (Fig.  3 B).  Activated MPF is 
capable of inducing GVBD in these cells (Taylor and Smith, 
1987). The fastest response time we ever observed for EGF- 
induced maturation (2-3 h) is similar to the fastest times ob- 
served for progesterone-induced maturation (Fig. 6 B; also 
see Reynhout et al., 1975), but slower than the response time 
observed for MPF (Wasserman and Masui,  1975a; also data 
not shown). Finally, we observed a several hour lag time be- 
tween the addition of EGF and activation of histone H1 ki- 
nase activity (Fig. 6), but no significant lag between the addi- 
tion of ligand and autophosphorylation of the EGF receptor 
(Fig. 3 B). Injection of oocytes with MPF induces an almost 
immediate activation of histone HI kinase activity (Labbe et 
al.,  1988).  Together  these  data  indicate that the hEGF-R 
mediates  its  action  through  an  unidentified  intermediate 
step(s). 
It is not yet certain whether internalization of the hEGF-R 
is necessary to induce maturation, but our data support the 
hypothesis that it acts to phosphorylate a substrate at the cell 
surface.  Although the c'973 hEGF-R was only internalized 
at one-third the rate of its wild-type counterpart, it was fully 
capable of inducing maturation. Indeed,  a requirement for 
activated receptors to reside at the oocyte surface would ex- 
plain why previous efforts to demonstrate a role for tyrosine 
kinases in maturation have failed, since those studies directly 
microinjected  kinases  into  the oocyte cytoplasm  (Mailer, 
1987;  Spivack et al.,  1984).  Direct microinjection of pro- 
gesterone also fails to induce maturation (Smith and Ecker, 
1971),  again  suggesting  that maturation triggered  by  hor- 
mone receptors may require action at the cell  surface. 
The ability of the hEGF-R to induce meiotic maturation 
in oocytes suggests that the fundamental processes regulat- 
ing the eucaryotic cell cycle are highly conserved during evo- 
lution. Our results also point to a central role for tyrosine 
kinases in both the activation and regulation of this process. 
However, it is noteworthy that maturation induced by mutant 
hEGF-R that are deficient in triggering some biological re- 
sponses,  such as  calcium  release,  more closely  resembles 
that produced by physiological agents.  Since progesterone 
treatment does not release  intracellular calcium  in oocytes 
(Cork et al.,  1987), this is an "inappropriate" hormonal re- 
sponse. The ability of wild-type hEGF-R to trigger responses 
typical of its normal context suggests that the response ma- 
chinery  is  similar  in  all cells  and that different  receptors 
function to orchestrate different responses.  Correct induc- 
tion of a final cellular response may require selective stimu- 
lation of the machinery.  Indeed,  it has been suggested that 
normal oocyte maturation occurs through both an inhibition 
and  stimulation  of  selective  signal  transduction  pathways 
(Smith, 1989). Thus qualitative as well as quantitative changes 
in growth factor receptors may be necessary to induce nor- 
mal cell division in an otherwise inappropriate context. Be- 
cause of the availability of a series of hEGF-R mutations with 
defined  alterations  in  autophosphorylation,  substrate  spe- 
cificity, ability to stimulate ion transport and receptor inter- 
nalization (Chen et al.,  1989), the oocyte is a good system 
in which to investigate these types of problems. 
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